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Abstract
Aims—Corneal perfusion chambers are
important tools in the development and
assessment of ophthalmic drugs. The aim
of this study was to design and test a
modified perfusion chamber suitable for
topical application of drugs to isolated
corneoscleral preparations, and which
allowed continuous monitoring of en-
dothelial cell function.
Methods—A polycarbonate and stainless
steel perfusion chamber was designed to
clamp corneas in a horizontal plane
suitable for topical drug delivery. En-
dothelial cell function was assessed by
ultrasonic pachymetry and specular mi-
croscopy during perfusion. Epithelial bar-
rier function was assessed by penetration
of fluorescein. Leakage was examined by
measuring penetration of a large protein,
IgG. Tissue architecture after perfusion
was examined by conventional histology.
Results—Corneas maintained a function-
ally and morphologically intact endothe-
lial monolayer during perfusion periods of
up to 14 hours. The epithelial barrier
function was well preserved. The tissue
clamp sealed the preparation eVectively
against leakage of macromolecules.
Conclusion—The new chamber device
forms a reliable tool for in vitro drug pen-
etration and toxicity studies in isolated
perfused corneoscleral tissue.
(Br J Ophthalmol 2001;85:450–453)
In vitro drug penetration and endothelial toxic-
ity studies on isolated corneoscleral preparations
are important for developing and testing oph-
thalmic drugs, drug vehicles, and irrigation
solutions.1–10 We describe a modified, simple
perfusion chamber that allows the topical appli-
cation of drugs in eye drop formulations to cor-
neal epithelium over periods of up to 14 hours.
The corneoscleral preparation is mounted hori-
zontally in the chamber between an air interface
on the epithelial side and an artificial fluid filled
anterior chamber on the corneal endothelial
side. An appropriate positive pressure gradient is
applied. The chamber design allows direct visual
and functional assessment of the endothelial
cells by specular microscopy and ultrasonic
pachymetry, respectively, at any stage during
perfusion and drug delivery.
Materials and methods
CORNEAL PERFUSION CHAMBER
The perfusion chamber was constructed from
polycarbonate and consisted of the main body,
a clamping sleeve, and a fixation ring (Fig 1).
The central cavity of the main body was 12 mm
in diameter and 3 mm in depth and, together
with the mounted cornea, formed the artificial
“anterior chamber”. The main body contained
channels for inflow and outflow perfusion lines
and an additional drainage channel that
connected with a channel in the clamping
sleeve. This channel allowed removal of excess
fluid after topical application, mimicking lac-
rimal drainage. Corneoscleral preparations
were placed over the central cavity of the main
body and secured with the clamping sleeve,
which covered both sclera and peripheral
cornea. The sleeve had two stainless steel guide
pins to direct its vertical movement without
twisting, minimising sheer stress and edge
damage to the cornea. The fixation ring
secured the sleeve and the underlying cornea to
the main chamber, creating a tight seal. The
fixation ring had a 1 mm pitch thread to allow
precise adjustment of the clamp. A construc-
tion plan for the perfusion chamber is shown in
Figure 2 (more detailed plans are available
from the authors).
CORNEAL PERFUSION USING THE CHAMBER
Normal pig eyes were obtained from a local
abattoir, transported to the laboratory at 4°C,
and used within 2–3 hours of enucleation. Eyes
had not been heat treated in the abattoir in any
way. Any eye with a collapsed anterior chamber
was discarded. Corneoscleral buttons were dis-
sected using standard eye bank techniques,
care being taken to minimise tissue distortion.
The preparation was mounted in the perfusion
chamber and the inflow tube was attached to a
peristaltic pump. Corneas were perfused with
BSS-Plus (Alcon Laboratories, Frenchs For-
est, NSW, Australia) at a flow rate of 1 ml/min.
The perfusate from the outflow tube was
collected in a reservoir and recirculated back
Figure 1 Corneal perfusion chamber shown without a
mounted cornea. The clamping sleeve sits on top of the
main body. The fixation ring that screws onto the main
body is shown on the left.
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into the chamber. The total fluid volume recir-
culating through the chamber, tubing, and res-
ervoir was 4 ml. The reservoir was elevated 25
cm above the level of the clamped cornea to
create a positive pressure of 18 mm Hg inside
the artificial anterior chamber, simulating
physiological conditions. The perfusion cham-
ber was surrounded with a brass heat exchange
block through which warm water circulated
from a 40°C water bath to maintain a chamber
temperature of approximately 35°C. The
corneal epithelial surface was kept moist by
applying BSS-Plus eye drops every 20 minutes.
Excess fluid was removed through the drainage
channel. A glass slide was used to cover the top
opening of the chamber on the epithelial side
to create a humid chamber, reduce evaporation
when measurements were not being taken, and
prevent drying of the corneal surface.
ASSESSMENT OF THE CORNEAL PENETRATION
BARRIER
Corneas were equilibrated with BSS-Plus for
45–60 minutes before the start of the experi-
ments. In some instances, corneal epithelium
was removed before perfusion by scraping the
epithelial surface with a scalpel blade.
Preservative-free sodium fluorescein eye drops
(2% w/v Minims, Chauvin Pharmaceuticals
Ltd, Essex) were applied to the corneal epithe-
lium at the rate of 50 µl every 20 minutes. Each
hour, 200–250 µl perfusate was removed from
the reservoir for analysis and replaced by the
same volume of fresh BSS-Plus. No correction
was applied for the dilution of fluorescein that
occurred when a sample was removed for test-
ing and was replaced by fresh BSS-Plus.
Penetration of fluorescein through the cornea
into the perfusate was measured in duplicate
100 µl samples of perfusate aliquoted into
ELISA plates. The optical density at 492 nm of
the samples was compared with those of
dilutions of a fluorescein standard on the same
plate. The detection threshold for fluorescein
was 250 ng/ml. To assess the tightness of the
tissue clamp, supernatant from a growing
culture of OX38 hybridoma (European Collec-
tion of Animal Cell Cultures) containing 1
µg/ml of mouse IgG with specificity for rat
CD4 was applied topically to the epithelium
every 20 minutes. Penetration of IgG through
the cornea was measured by high sensitivity
flow cytometry11 on normal rat thymocytes,
which are CD4 positive. The sensitivity of
detection was 1 in 30 000; replicates were
assayed and mean fluorescence intensity re-
corded.
ASSESSMENT OF CORNEAL TISSUE VIABILITY
Tissue viability was assessed by measuring cor-
neal thickness every 60 minutes with a hand
held ultrasonic pachymeter (BV International,
Clermont-Ferrand, France). During the initial
equilibration period, three or more pachymetry
measurements were taken every 15 minutes to
identify corneas with compromised endothelial
pump function (two of 23 corneas had to be
replaced before the start of the experiment).
Once an experiment had been initiated, an
increase in corneal thickness of more than 10%
compared with the initial value was regarded as
reflecting endothelial dysfunction and the
experiment was discarded (one of 23 experi-
ments). Endothelial cell photography was per-
formed with the Keeler-Konan contact specu-
lar microscope using 320 ASA Kodak tungsten
slide film. At the end of each experiment, cor-
neoscleral buttons were fixed in buVered
formalin, embedded in paraYn, and cut at 10
µm. Sections were stained with periodic acid
SchiV and examined by light microscopy.
Results
PACHYMETRY DURING CORNEAL PERFUSION
Eight pig corneas were perfused with BSS-Plus
and the corneal thickness was measured hourly
by ultrasound pachymetry for 4–14 hours. Ini-
tial mean pachymetry values were 729 µm (SD
59) µm. The maximum observed increase from
baseline in any individual pig cornea at any
time point was less than 10% (Fig 3). The
experiment was repeated on four normal cat
corneas with similar results: corneal thickness
increased by no more than 10% over an 8 hour
observation period (data not shown). After an
Figure 2 Chamber design: (A) main body, (B) clamping
sleeve, and (C) fixation ring. All parts were made of
polycarbonate and stainless steel. Corneas are clamped






















Figure 3 Corneal thickness (mean (SD)) as measured by
pachymetry plotted against perfusion time for isolated
perfused pig corneas mounted in the modified perfusion
chamber. Toxic destruction of the endothelium by a brief
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initial perfusion period of 60 minutes, the
endothelium of one pig cornea was intention-
ally destroyed by a 60 second perfusion with
100% ethanol before the perfusion was contin-
ued with BSS-Plus. Endothelial destruction
was followed by a rapid increase in corneal
thickness within 15 minutes and the corneal
thickness almost doubled from its baseline
level during the following 4 hours (Fig 3).
SPECULAR MICROSCOPY DURING CORNEAL
PERFUSION
The morphological integrity of the endothelial
monolayer was examined by specular micros-
copy in three pig corneas during perfusion.
Representative photographs of endothelium in
a freshly enucleated whole eye and in a cornea
after 4 hours of perfusion with BSS-Plus in the
perfusion chamber are shown in Figure 4A and
B, respectively. Minimal cell damage was
observed.
ASSESSMENT OF CORNEAL BARRIER FUNCTION
Penetration of sodium fluorescein was
measured in three corneas with epithelium and
in four corneas after removal of epithelium. In
corneas with preserved epithelium, fluorescein
became detectable in the perfusate after 3
hours and increased slowly thereafter in a
linear fashion over the experimental period of
10 hours (Fig 5). In corneas without epithe-
lium, fluorescein was detectable in the per-
fusate 15 minutes after application of the first
drop and increased thereafter 200 times faster
than in corneas with preserved epithelium
(Fig 5).
EFFECTIVENESS OF THE CORNEAL CLAMP
Three corneas without epithelium were ex-
posed to topically applied anti-CD4 IgG
antibody three times an hour for 4–14 hours.
No IgG binding activity was observed in the
perfusate for up to 14 hours, indicating that the
corneal clamp formed an eVective seal against
leakage into the perfusion chamber (data not
shown).
END POINT HISTOLOGY
End point histology of six pig corneas showed
intact corneal epithelium after 14 hours of per-
fusion. The epithelium was compressed in the
area of the clamp but the superficial epithelial
cells appeared well preserved (Fig 4C). The
basal and intermediate epithelial cells seemed
to have been forced laterally to the side of the
clamping point. The corneal stroma, De-
scemet’s membrane, and corneal endothelium
were intact.
Discussion
An ideal perfusion chamber should allow
perfusion of an isolated cornea for a substantial
period, with maintenance of a viable corneal
endothelial monolayer and an intact epithelial
barrier function. The chamber must not leak
around the clamp. We describe a modified cor-
neal perfusion chamber that meets these essen-
tial criteria, that permits topical application of
drugs to the corneal epithelium at an air
epithelial interface, and that has the advantage
that assessment of endothelial pump function
can readily be performed throughout per-
fusion.
To assess the function of the perfusion
device described, the viability of corneal
endothelium during perfusion was confirmed
by regular pachymetry and specular micros-
copy over periods of up to 14 hours. The thick-
ness of corneas perfused for 14 hours increased
Figure 4 Specular microscopy (A, B) and histology (C)
of a perfused pig cornea. (A) Endothelium before tissue
dissection, (B) endothelium after 4 hours of perfusion
(magnification ×40), (C) epithelium after perfusion for 10
hours, topical BSS eye drops every 20 minutes (periodic
acid SchiV stain, magnification ×100).
Figure 5 Fluorescein penetration (mean (SD) of replicate determinations) through pig
corneas with or without epithelium. No correction was applied for the dilution of fluorescein
that occurred when a sample was removed for testing and was replaced by fresh BSS-Plus.
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by less than 10% over baseline values, indicat-
ing that the corneal endothelial cell pump
function was capable of maintaining appropri-
ate tissue hydration despite a positive perfusion
pressure of 18 mm Hg.
Specular microscopy performed during per-
fusion experiments showed morphologically
well preserved endothelial cells. Destruction of
endothelial cells by brief perfusion with
ethanol resulted in an immediate and progres-
sive corneal swelling. The perfusate in our
device was not continuously aerated. Instead,
200–250 µl of the total perfusate volume was
replaced every hour, mimicking to some extent
the normal human aqueous humour turnover
of 120–300 µl per hour. This design simplifica-
tion clearly permitted supply of enough
glucose and oxidised glutathione to maintain
endothelial cell function.
Fluorescein is commonly used in humans to
investigate epithelial barrier function.12 The
integrity of the epithelial barrier in isolated
corneas perfused in our device was tested by
applying fluorescein topically as an eye drop.
Fluorescein was first detected in the perfusate
after a time lag of 3 hours, followed by a slow
increase until the end of the experiment at 10
hours. Destruction of the epithelial barrier
resulted in a 200-fold increase in penetration of
fluorescein into the artificial anterior chamber.
The low permeability of normal corneas to
fluorescein over periods of 10 hours indicated
that the epithelial barrier was well preserved
during tissue dissection, mounting on to the
chamber, and subsequent perfusion.
Potential leakage through the chamber was
excluded by confirming that IgG, a molecule
known to penetrate the cornea only within days
to weeks,13 did not penetrate through the
perfused cornea over periods of up to 14 hours
when applied topically. Even after removal of
the epithelium, no IgG was detected in the
perfusate of three corneas perfused for up to 14
hours, indicating that the tissue clamp per-
formed reliably. End point histology of per-
fused corneas showed that the tissue was well
preserved.
There are several basic designs of corneal
perfusion chamber. In Ussing-type chambers,
the corneal tissue is clamped in the vertical
plane between two perfusion baths.1 4 6–9 Drugs
are added to one bath (usually on the corneal
epithelial side of the chamber) and corneal
penetration is assessed by measuring drug con-
centration in the other bath (usually on the
corneal endothelial side of the chamber).
Endothelial cell viability is assessed at the end
of the experiment by calculating tissue hydra-
tion from wet and dry tissue weights. This
basic chamber design has some disadvantages
in that the corneal epithelium is continuously
immersed in a stirred bath, and the pump
function of the endothelial monolayer can only
be assessed after drying the cornea at the
experimental end point, an error prone method
at best.14 Further, it can be diYcult to achieve
the pressure gradient across the perfused tissue
that is essential for normal function. A
modified chamber in which the cornea was
clamped in the horizontal plane was described
by Dikstein and Maurice.2 The design permit-
ted specular microscopy of the corneal en-
dothelium to be performed but the corneal
surface was covered with silicone oil, excluding
direct topical application of drugs as eye drops.
The modifications of Krohn and Breitfeller3
involved use of a humid chamber (rather than a
bath) on the epithelial side of the cornea, but
the clamping device did not allow ready assess-
ment of corneal endothelial cell viability by
corneal pachymetry or specular microscopy.
In the modification described here the
cornea is clamped in a horizontal plane, the
epithelial surface of the cornea is exposed to air
in a humid chamber rather than being
immersed in a perfusion bath, the design of the
clamp allows access for a pachymeter probe or
specular microscope cone, and a constant per-
fusion pressure in the range of 8–25 mm Hg
can easily be maintained. Topical application
of individual eye drops is straightforward. In
our experiments we recirculated the perfusate,
but a single pass system could equally well have
been used. Our chamber is similar to the device
described by Bourne and his colleagues,10 but
is somewhat simpler. A stirrer was not found to
be necessary for the perfusate (a benefit of the
relatively high perfusion rate). The inclusion of
a port for drainage of solutions applied to the
epithelial surface was found to be a helpful
modification. We have shown that the penetra-
tion chamber is suitable for both pig and cat
corneas, and the dimensions of the device are
such that it should also be useful for the human
cornea, for which it was originally designed.
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